Company Encyclopedia
View More
name
Ping An Biomedical
PASW.US
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China. Its services include market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company offers a range of yarn products, textiles, and finished garments; and real estate property investment and warehousing services. It serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers.
43.47 B
PASW.USMarket value -Rank by Market Cap -/-

Financial Score

09/01/2026 Update
D
DistributorsIndustry
Industry Ranking22/28
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE66.51%A
    • Profit Margin-9.57%D
    • Gross Margin-3.80%E
  • Growth ScoreE
    • Revenue YoY-37.44%E
    • Net Profit YoY-1126.92%E
    • Total Assets YoY-39.24%E
    • Net Assets YoY-110.07%E
  • Cash ScoreE
    • Cash Flow Margin-1044.81%E
    • OCF YoY-37.44%E
  • Operating ScoreA
    • Turnover0.94A
  • Debt ScoreE
    • Gearing Ratio124.16%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Morning Trend | Ping An Biomedical continues to decline, is the main force's bottom-fishing window about to open?

    Ping An Biomedical (PASW.US) has been hovering at low levels for several days, with evident capital hesitation. Community experts have been asking questions: "With the drop like this, will the main funds dare to smash the market to accumulate shares? Is the bottom-fishing opportunity coming soon?" Recently, Ping An Biomedical has been affected by revenue data, and the downward trend has been the main theme. The stock price has dipped to around $1.80, with technical support levels precarious and intraday trading sluggish. Community discussions are polarized; one group remains bearish, waiting for a breakdown to liquidate, while another group of "wolf pack" traders is closely watching for the moment when the main funds smash the market to prepare for a strike. From the perspective of North American data and capital flow, the controlling main funds have not yet significantly accumulated shares, but the bottom chips are starting to alternate, and the intention of capital to ambush at the bottom has increased. The likelihood of a "bounce from oversold conditions" due to continuous declines is gradually rising. If there is a sudden influx of large orders or a short-term increase in trading volume during the intraday session, it could trigger a fierce rebound. In terms of operation, it is crucial to pay attention to whether the $1.80 level can be maintained. If there is a sudden surge accompanied by increased volume, it would be a short-term strike opportunity. Otherwise, there is still a possibility of continued fluctuations at the bottom, and it is not advisable to take heavy positions until the main funds reveal their cards. The bottom-fishing window is just a line away; whether to profit or incur losses depends entirely on whether the main funds can act decisively in the intraday session

    Technical Forecast·
    Technical Forecast·

    Morning Trend | Ping An Biomedical experiences significant fluctuations, is a main force lifting signal about to unfold?

    Ping An Biomedical (PASW.US) has recently experienced significant intraday volatility, and the community's interest in whether "the main force will launch a round of concentrated rally" is growing. The long-short game is becoming increasingly intense; although there have been several pullbacks recently, the continuous late-session rallies and periodic large orders flowing into the market indicate that bottom funds are actively defending the price. The stock price has repeatedly fallen to $1.20 before recovering, and trading activity is becoming more vibrant. Currently, the main funds are mainly engaging in unusual trading around the bottom area, and a short-term main rise could be initiated at any time. There are many doubts about the company's fundamentals in the market, but once favorable news stimulates the stock, it is expected that funds in the sector will quickly follow suit. Cautious traders suggest patiently waiting for signals of unusual trading; if there is a significant increase in volume today, short-term profit opportunities will arise. The strategy suggests not to bet too early on large positions but to wait for the main force to push the price above around $1.30 before actively following to go long. Overall, the capital game in Ping An Biomedical is very active, but it still requires the main force to ignite the rally. Next, we will focus on whether the main force's actions can trigger a short-term rise, as the window for going long may open at any time. Before the signal arrives, it is advisable to proceed with caution and not to blindly take large positions

    Technical Forecast·
    Technical Forecast·

    Morning Trend | Ping An Biomedical experiences unusual volume, is there significant movement from short-term funds?

    Ping An Biomedical (PASW.US) showed significant fluctuations yesterday, with a sudden increase in trading volume during the session as funds rushed to buy, leading to two consecutive short-term price increases, placing it among the top gainers in the sector. Community traders are increasingly focused on short-term trading, with many following suit, reflecting strong expectations for fund inflows into the sector. In terms of the industry, the medical innovation and biotechnology sectors have seen active sentiment this week, with the topic of blockchain + biomedical policies being hotly discussed again, and the information linkage effect between Shanghai, Shenzhen, Hong Kong, and the U.S. is evident. Ping An Biomedical relies on innovative drugs and overseas cooperation dynamics, gaining favor from short-term main players. Technically, the stock broke through the consolidation zone of the past two weeks with a strong upward movement, and a large volume of trading has poured in, with MACD and RSI indicators showing short-term strength. If the momentum continues without a pullback, the main upward space is likely to extend. However, if the volume does not sustain or if there is significant turnover at high levels, it may lead to short-term profit-taking and increased volatility. Today's market and sector atmosphere will directly affect the rhythm of fund inflows and outflows. It is important to maintain the first wave of the main line in the gaining sector and closely observe the flow of funds to determine entry and exit. The fluctuations in Ping An Biomedical during the session are closely monitored by short-term speculative funds in the biomedical sector

    Technical Forecast·
    Technical Forecast·